
Anthony R. Shumate
Examiner (ID: 9454, Phone: (571)270-5546 , Office: P/1773 )
| Most Active Art Unit | 1776 |
| Art Unit(s) | 1772, 1776, 1775, 1773, 1797 |
| Total Applications | 1063 |
| Issued Applications | 781 |
| Pending Applications | 73 |
| Abandoned Applications | 233 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 17911283
[patent_doc_number] => 20220313678
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-06
[patent_title] => SPRAY DRIED NICOTINE FOR INCLUSION IN ORAL PRODUCTS
[patent_app_type] => utility
[patent_app_number] => 17/223756
[patent_app_country] => US
[patent_app_date] => 2021-04-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 42443
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 84
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17223756
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/223756 | SPRAY DRIED NICOTINE FOR INCLUSION IN ORAL PRODUCTS | Apr 5, 2021 | Pending |
Array
(
[id] => 18361673
[patent_doc_number] => 20230143264
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-11
[patent_title] => COMPOSITION HAVING IMPROVED VOLUNTARY ACCEPTANCE
[patent_app_type] => utility
[patent_app_number] => 17/916195
[patent_app_country] => US
[patent_app_date] => 2021-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11311
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17916195
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/916195 | Composition having improved voluntary acceptance | Mar 29, 2021 | Issued |
Array
(
[id] => 18295905
[patent_doc_number] => 20230105591
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-06
[patent_title] => TABLET, MEDICINE, METHODS FOR PRODUCING THESE, AND KIT
[patent_app_type] => utility
[patent_app_number] => 17/911040
[patent_app_country] => US
[patent_app_date] => 2021-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9818
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17911040
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/911040 | TABLET, MEDICINE, METHODS FOR PRODUCING THESE, AND KIT | Mar 28, 2021 | Pending |
Array
(
[id] => 19825280
[patent_doc_number] => 12246034
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-03-11
[patent_title] => Animal feed supplement and method
[patent_app_type] => utility
[patent_app_number] => 17/213013
[patent_app_country] => US
[patent_app_date] => 2021-03-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9482
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 101
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17213013
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/213013 | Animal feed supplement and method | Mar 24, 2021 | Issued |
Array
(
[id] => 17035026
[patent_doc_number] => 20210251984
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-19
[patent_title] => Pharmaceutical Compositions Comprising Levocetirizine
[patent_app_type] => utility
[patent_app_number] => 17/191365
[patent_app_country] => US
[patent_app_date] => 2021-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15853
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17191365
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/191365 | Pharmaceutical Compositions Comprising Levocetirizine | Mar 2, 2021 | Abandoned |
Array
(
[id] => 17250066
[patent_doc_number] => 11185535
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-11-30
[patent_title] => Amorphous kinase inhibitor formulations and methods of use thereof
[patent_app_type] => utility
[patent_app_number] => 17/180234
[patent_app_country] => US
[patent_app_date] => 2021-02-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 33029
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 194
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17180234
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/180234 | Amorphous kinase inhibitor formulations and methods of use thereof | Feb 18, 2021 | Issued |
Array
(
[id] => 18610737
[patent_doc_number] => 20230277467
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-07
[patent_title] => FILM-COATED TABLET
[patent_app_type] => utility
[patent_app_number] => 18/019033
[patent_app_country] => US
[patent_app_date] => 2021-02-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4986
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 115
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18019033
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/019033 | FILM-COATED TABLET | Feb 17, 2021 | Pending |
Array
(
[id] => 17095285
[patent_doc_number] => 20210283076
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-16
[patent_title] => LACOSAMIDE PHARMACEUTICAL COMPOSITION AND DOSAGE FORM THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/177485
[patent_app_country] => US
[patent_app_date] => 2021-02-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20857
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 152
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17177485
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/177485 | Lacosamide pharmaceutical composition and dosage form thereof | Feb 16, 2021 | Issued |
Array
(
[id] => 18747123
[patent_doc_number] => 11806414
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-11-07
[patent_title] => Silica-including microcapsule resin particles, method for producing same, and application thereof
[patent_app_type] => utility
[patent_app_number] => 17/173334
[patent_app_country] => US
[patent_app_date] => 2021-02-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 9
[patent_no_of_words] => 10726
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 83
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17173334
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/173334 | Silica-including microcapsule resin particles, method for producing same, and application thereof | Feb 10, 2021 | Issued |
Array
(
[id] => 16853401
[patent_doc_number] => 20210154146
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-27
[patent_title] => COMPOSITIONS AND METHODS FOR TREATING DISORDERS AMELIORATED BY MUSCARINIC RECEPTOR ACTIVATION
[patent_app_type] => utility
[patent_app_number] => 17/167714
[patent_app_country] => US
[patent_app_date] => 2021-02-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27034
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17167714
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/167714 | COMPOSITIONS AND METHODS FOR TREATING DISORDERS AMELIORATED BY MUSCARINIC RECEPTOR ACTIVATION | Feb 3, 2021 | Abandoned |
Array
(
[id] => 17035085
[patent_doc_number] => 20210252043
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-19
[patent_title] => COMPOSITIONS AND METHODS FOR TREATING DISEASES OR DISORDERS USING EXTNDE RELEASE NITRIC OXIDE RELEASING SOLUTIONS
[patent_app_type] => utility
[patent_app_number] => 17/164764
[patent_app_country] => US
[patent_app_date] => 2021-02-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13815
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17164764
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/164764 | COMPOSITIONS AND METHODS FOR TREATING DISEASES OR DISORDERS USING EXTNDE RELEASE NITRIC OXIDE RELEASING SOLUTIONS | Jan 31, 2021 | Abandoned |
Array
(
[id] => 18738104
[patent_doc_number] => 20230347019
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-02
[patent_title] => IMPROVED BONE GRAFT SUBSTITUTE FORMULATION
[patent_app_type] => utility
[patent_app_number] => 17/796529
[patent_app_country] => US
[patent_app_date] => 2021-01-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12056
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -78
[patent_words_short_claim] => 83
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17796529
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/796529 | IMPROVED BONE GRAFT SUBSTITUTE FORMULATION | Jan 28, 2021 | Pending |
Array
(
[id] => 20356183
[patent_doc_number] => 12472162
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-11-18
[patent_title] => Ready-to-use, terminally sterile packaging for surgical antiseptic and method of use
[patent_app_type] => utility
[patent_app_number] => 17/152565
[patent_app_country] => US
[patent_app_date] => 2021-01-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 1142
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 86
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17152565
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/152565 | Ready-to-use, terminally sterile packaging for surgical antiseptic and method of use | Jan 18, 2021 | Issued |
Array
(
[id] => 18558637
[patent_doc_number] => 11723862
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-08-15
[patent_title] => Dosage form with sustained release melatonin pellets
[patent_app_type] => utility
[patent_app_number] => 17/150049
[patent_app_country] => US
[patent_app_date] => 2021-01-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5134
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 134
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17150049
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/150049 | Dosage form with sustained release melatonin pellets | Jan 14, 2021 | Issued |
Array
(
[id] => 16791759
[patent_doc_number] => 20210121576
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-29
[patent_title] => DERMOCOSMETIC COMPOSITIONS INCLUDING GLYCEROL-SEBACATE
[patent_app_type] => utility
[patent_app_number] => 17/141918
[patent_app_country] => US
[patent_app_date] => 2021-01-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6425
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17141918
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/141918 | DERMOCOSMETIC COMPOSITIONS INCLUDING GLYCEROL-SEBACATE | Jan 4, 2021 | Abandoned |
Array
(
[id] => 18962955
[patent_doc_number] => 11896694
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-02-13
[patent_title] => Compositions for removing nail polish
[patent_app_type] => utility
[patent_app_number] => 17/140567
[patent_app_country] => US
[patent_app_date] => 2021-01-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5702
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 98
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17140567
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/140567 | Compositions for removing nail polish | Jan 3, 2021 | Issued |
Array
(
[id] => 16946532
[patent_doc_number] => 20210205223
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-08
[patent_title] => PROPELLANT-FREE FORMULATION FOR INHALATION
[patent_app_type] => utility
[patent_app_number] => 17/137559
[patent_app_country] => US
[patent_app_date] => 2020-12-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5756
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17137559
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/137559 | PROPELLANT-FREE FORMULATION FOR INHALATION | Dec 29, 2020 | Abandoned |
Array
(
[id] => 19324904
[patent_doc_number] => 12042557
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-07-23
[patent_title] => Rapid establishment and/or termination of substantial steady-state drug delivery
[patent_app_type] => utility
[patent_app_number] => 17/121359
[patent_app_country] => US
[patent_app_date] => 2020-12-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 21
[patent_no_of_words] => 29901
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 130
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17121359
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/121359 | Rapid establishment and/or termination of substantial steady-state drug delivery | Dec 13, 2020 | Issued |
Array
(
[id] => 18517737
[patent_doc_number] => 11707610
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-07-25
[patent_title] => Ingestible device for delivery of therapeutic agent to the gastrointestinal tract
[patent_app_type] => utility
[patent_app_number] => 17/784453
[patent_app_country] => US
[patent_app_date] => 2020-12-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 37
[patent_figures_cnt] => 78
[patent_no_of_words] => 111322
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 251
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17784453
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/784453 | Ingestible device for delivery of therapeutic agent to the gastrointestinal tract | Dec 10, 2020 | Issued |
Array
(
[id] => 16718453
[patent_doc_number] => 20210085600
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-25
[patent_title] => THERAPEUTIC AGENT PREPARATIONS FOR DELIVERY INTO A LUMEN OF THE INTESTINAL TRACT USING A SWALLOWABLE DRUG DELIVERY DEVICE
[patent_app_type] => utility
[patent_app_number] => 17/112458
[patent_app_country] => US
[patent_app_date] => 2020-12-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23429
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 100
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17112458
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/112458 | Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device | Dec 3, 2020 | Issued |